ARMATA PHARMACEUTICALS, INC. Accounts Payable
ARMATA PHARMACEUTICALS, INC. (ARMP) had Accounts Payable of $1.19 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-12
- 2026-06-30: Accounts Payable, Current $1.19M.
- 2026-03-31: Accounts Payable, Current $660.00K.
- 2025-12-31: Accounts Payable, Current $921.00K.
- 2025-09-30: Accounts Payable, Current $1.28M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.19M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $660.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $921.00K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $1.28M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $965.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $981.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $766.00K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $1.81M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.74M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $2.06M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $1.58M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $3.77M 10-Q · filed 2023-11-14 | |
| 2022-12-31 | $1.68M 10-K · filed 2024-03-21 | |
| 2021-12-31 | $1.14M 10-K · filed 2023-03-16 | |
| 2020-12-31 | $956.00K 10-K · filed 2022-03-17 | |
| 2019-12-31 | $547.00K 10-K · filed 2021-03-18 | |
| 2018-12-31 | $415.00K 10-K · filed 2020-03-19 | $729.00K 10-K · filed 2019-03-25 |
| 2018-09-30 | $714.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $682.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $810.00K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $578.00K 10-K · filed 2019-03-25 | |
| 2016-12-31 | $1.06M 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |